Patents by Inventor Nathalie Barthez

Nathalie Barthez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions comprising at least one aqueous phase and at least one fatty phase which comprises avermectin compounds
    Patent number: 9592249
    Abstract: Pharmaceutical/dermatological emulsions containing at least one avermectin compound, notably ivermectin, include at least one fatty phase and at least one aqueous phase, the at least one avermectin compound being solubilized in the fatty phase, which emulsions are useful for the treatment of a variety of dermatological conditions/afflictions, in particular rosacea.
    Type: Grant
    Filed: December 19, 2012
    Date of Patent: March 14, 2017
    Assignee: GALDERMA S.A.
    Inventors: Fanny Diaz-Astruc, Nathalie Barthez, Sandrine Segura-Orsoni
  • PETROLEUM JELLY-FREE UNGUENT COMPOSITIONS COMPRISING VITAMIN D COMPOUNDS AND OPTIONALLY STEROIDAL ANTI-INFLAMMATORY AGENTS
    Publication number: 20140256689
    Abstract: Novel compositions in petroleum jelly-free unguent form, in particular for topical application, contain a vitamin D compound and optionally an active agent of the family of steroidal anti-inflammatory agents.
    Type: Application
    Filed: May 16, 2014
    Publication date: September 11, 2014
    Applicant: GALDERMA S.A.
    Inventors: Nathalie WILLCOX, Nathalie Barthez, Karine Nadau-Fourcade, Claire Mallard
  • PETROLEUM JELLY-FREE UNGUENT COMPOSITIONS COMPRISING VITAMIN D COMPOUNDS AND OPTIONALLY STEROIDAL ANTI-INFLAMMATORY AGENTS
    Publication number: 20140243297
    Abstract: Novel compositions in petroleum jelly-free unguent form, in particular for topical application, contain a vitamin D compound and optionally an active agent of the family of steroidal anti-inflammatory agents.
    Type: Application
    Filed: May 1, 2014
    Publication date: August 28, 2014
    Applicant: GALDERMA S.A.
    Inventors: Nathalie WILLCOX, Nathalie BARTHEZ, Karine NADAU-FORUCADE, Claire MALLARD
  • Petroleum jelly-free unguent compositions comprising vitamin D compounds and optionally steroidal anti-inflammatory agents
    Patent number: 8741878
    Abstract: Novel compositions in petroleum jelly-free unguent form, in particular for topical application, contain a vitamin D compound and optionally an active agent of the family of steroidal anti-inflammatory agents.
    Type: Grant
    Filed: May 29, 2009
    Date of Patent: June 3, 2014
    Assignee: Galderma S.A.
    Inventors: Nathalie Willcox, Nathalie Barthez, Karine Nadau-Fourcade, Claire Mallard
  • Petroleum jelly-free unguent compositions comprising vitamin D compounds and optionally steroidal anti-inflammatory agents
    Patent number: 8741879
    Abstract: Novel compositions in petroleum jelly-free unguent form, in particular for topical application, contain a vitamin D compound and optionally an active agent of the family of steroidal anti-inflammatory agents.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: June 3, 2014
    Assignee: Galderma S.A.
    Inventors: Nathalie Willcox, Nathalie Barthez, Karine Nadau-Fourcade, Claire Mallard
  • TOPICAL PHARMACEUTICAL COMPOSITION CONTAINING A WATER-SENSITIVE ACTIVE PRINCIPLE
    Publication number: 20140100181
    Abstract: A topical pharmaceutical composition including, as a pharmaceutical active agent, a water-sensitive compound in a solubilised form in a physiologically acceptable medium is described. A method for preparing such a composition, and uses thereof in dermatology are also described.
    Type: Application
    Filed: December 9, 2013
    Publication date: April 10, 2014
    Applicant: Galderma S.A.
    Inventors: Karine NADAU-FOURCADE, Nathalie Barthez, Laetitia Mazeau
  • Compositions comprising at least one aqueous phase and at least one fatty phase which comprises avermectin compounds
    Patent number: 8362069
    Abstract: Pharmaceutical/dermatological emulsions containing at least one avermectin compound, notably ivermectin, include at least one fatty phase and at least one aqueous phase, the at least one avermectin compound being solubilized in the fatty phase, which emulsions are useful for the treatment of a variety of dermatological conditions/afflictions, in particular rosacea.
    Type: Grant
    Filed: October 17, 2008
    Date of Patent: January 29, 2013
    Assignee: Galderma S.A.
    Inventors: Fanny Diaz-Astruc, Nathalie Barthez, Sandrine Segura-Orsoni
  • PETROLEUM JELLY-FREE UNGUENT COMPOSITIONS COMPRISING VITAMIN D COMPOUNDS AND OPTIONALLY STEROIDAL ANTI-INFLAMMATORY AGENTS
    Publication number: 20130012484
    Abstract: Novel compositions in petroleum jelly-free unguent form, in particular for topical application, contain a vitamin D compound and optionally an active agent of the family of steroidal anti-inflammatory agents.
    Type: Application
    Filed: September 14, 2012
    Publication date: January 10, 2013
    Applicant: GALDERMA S.A.
    Inventors: Nathalie WILLCOX, Nathalie BARTHEZ, Karine NADAU-FOURCADE, Claire MALLARD
  • TOPICAL PHARMACEUTICAL COMPOSITION CONTAINING A WATER-SENSITIVE ACTIVE PRINCIPLE
    Publication number: 20120004200
    Abstract: A topical pharmaceutical composition including, as a pharmaceutical active agent, a water-sensitive compound in a solubilised form in a physiologically acceptable medium is described. A method for preparing such a composition, and uses thereof in dermatology are also described.
    Type: Application
    Filed: December 21, 2009
    Publication date: January 5, 2012
    Applicant: GALDERMA S.A.
    Inventors: Karine Nadau-Fourcade, Nathalie Barthez, Laëtitia Mazeau
  • Pharmaceutical composition comprising oleaginous ointments and vitamin D or its derivatives in the solubilized state
    Publication number: 20100286285
    Abstract: The present invention relates to an anhydrous pharmaceutical composition for use in the treatment of psoriasis and other skin disorders, characterized in that it comprises an oleaginous ointment and, as active ingredient, a compound chosen from vitamin D and its derivatives, said active agent being in a solubilized form in said composition.
    Type: Application
    Filed: November 16, 2007
    Publication date: November 11, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Nathalie Barthez, Sandrine Orsoni, Laurent Fredon
  • Petroleum jelly-free unguent compositions comprising vitamin D compounds and optionally steroidal anti-inflammatory agents
    Publication number: 20090298801
    Abstract: Novel compositions in petroleum jelly-free unguent form, in particular for topical application, contain a vitamin D compound and optionally an active agent of the family of steroidal anti-inflammatory agents.
    Type: Application
    Filed: May 29, 2009
    Publication date: December 3, 2009
    Applicant: GALDERMA S.A.
    Inventors: Nathalie Willcox, Nathalie Barthez, Karine NADAU-FOURCADE, Claire MALLARD
  • COMPOSITIONS COMPRISING AT LEAST ONE AQUEOUS PHASE AND AT LEAST ONE FATTY PHASE WHICH COMPRISES AVERMECTIN COMPOUNDS
    Publication number: 20090136574
    Abstract: Pharmaceutical/dermatological emulsions containing at least one avermectin compound, notably ivermectin, include at least one fatty phase and at least one aqueous phase, the at least one avermectin compound being solubilized in the fatty phase, which emulsions are useful for the treatment of a variety of dermatological conditions/afflictions, in particular rosacea.
    Type: Application
    Filed: October 17, 2008
    Publication date: May 28, 2009
    Applicant: GALDERMA S.A.
    Inventors: Fanny Diaz-Astruc, Nathalie Barthez, Sandrine Segura-Orsoni
  • Pharmaceutical compositions comprising organopolysiloxane elastomers and solubilized bioactive compounds
    Publication number: 20080194528
    Abstract: Stable, anhydrous pharmaceutical compositions contain an organopolysiloxane elastomer and, as bioactive ingredient, at least one vitamin D compound in a solubilized form, and are useful for the topical treatment of psoriasis and other skin disorders/afflictions.
    Type: Application
    Filed: December 17, 2007
    Publication date: August 14, 2008
    Applicant: GALDERMA RESEARCH AND DEVELOPMENT
    Inventors: Nathalie Barthez, Emilie Tonglet, Sandrine Orsoni, Laurent Fredon
  • Metronidazole-based tinted topical pharmaceutical compositions
    Publication number: 20060182688
    Abstract: Topically applicable pharmaceutical compositions suited for the treatment of dermatological complaints, conditions or afflictions, notably rosacea, contain a thus effective amount of metronidazole and at least one dye effective to impart a green color thereto, formulated into a topically applicable, pharmaceutically acceptable vehicle therefor.
    Type: Application
    Filed: December 19, 2005
    Publication date: August 17, 2006
    Applicant: GALDERMA S.A.
    Inventors: Nathalie Barthez, Sandrine Orsoni, Jessica Faust, Vincent Manetta, Laurent Fredon
  • Oleaginous ointments comprising two solubilized bioactive agents for the treatment of psoriasis
    Publication number: 20050281848
    Abstract: Topically applicable, anhydrous, hydrophobic and physically/chemically stable dermatological/pharmaceutical oleaginous ointments having effective release/penetration capacity and also having therapeutically effective amounts of calcitriol and clobetasol 17-propionate solubilized therein, are well suited for the treatment of psoriasis.
    Type: Application
    Filed: October 7, 2004
    Publication date: December 22, 2005
    Applicant: GALDERMA S.A.
    Inventors: Leslie Zanutto, Sandrine Orsoni, Nathalie Barthez